MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition:   Breast CancerInterventions:   Drug: MK-3475;   Behavioral: Follow Up/Phone CallSponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials

MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition:   Breast CancerInterventions:   Drug: MK-3475;   Behavioral: Follow Up/Phone CallSponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.Not yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials

MK-3475 for Metastatic Inflammatory Breast Cancer (MIBC)
Condition:   Breast CancerInterventions:   Drug: MK-3475;   Behavioral: Follow Up/Phone CallSponsors:   M.D. Anderson Cancer Center;   Merck Sharp & Dohme Corp.Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2015 Category: Research Source Type: clinical trials

Nintedanib For HER2-negative Metastatic Inflammatory Breast Cancer (MIBC)
Condition:   Breast CancerInterventions:   Drug: BIBF 1120;   Behavioral: Phone CallSponsors:   M.D. Anderson Cancer Center;   Boehringer IngelheimNot yet recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2015 Category: Research Source Type: clinical trials

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer
Condition:   Inflammatory Breast CancerInterventions:   Drug: Docetaxel;   Drug: Cyclophosphamide;   Drug: EpirubicinSponsor:   UNICANCERCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2014 Category: Research Source Type: clinical trials

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer
Conditions:   HER2-negative Breast Cancer;   Inflammatory Breast Cancer;   Male Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast CancerInterventions:   Drug: Romidepsin;   Drug: AbraxaneSponsors:   Thomas Jefferson University;   Celgene CorporationRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 5, 2013 Category: Research Source Type: clinical trials